O'Sullivan J - Search Results

1

Decreased mitochondrial DNA mutagenesis in human colorectal cancer.

Ericson NG, Kulawiec M, Vermulst M, Sheahan K, O'Sullivan J, Salk JJ, Bielas JH. Ericson NG, et al. PLoS Genet. 2012;8(6):e1002689. doi: 10.1371/journal.pgen.1002689. Epub 2012 Jun 7. PLoS Genet. 2012. PMID: 22685414 Free PMC article.

2

Tumor budding is a strong and reproducible prognostic marker in T3N0 colorectal cancer.

Wang LM, Kevans D, Mulcahy H, O'Sullivan J, Fennelly D, Hyland J, O'Donoghue D, Sheahan K. Wang LM, et al. Am J Surg Pathol. 2009 Jan;33(1):134-41. doi: 10.1097/PAS.0b013e318184cd55. Am J Surg Pathol. 2009. PMID: 18971777

3

Increased topoisomerase IIalpha expression in colorectal cancer is associated with advanced disease and chemotherapeutic resistance via inhibition of apoptosis.

Coss A, Tosetto M, Fox EJ, Sapetto-Rebow B, Gorman S, Kennedy BN, Lloyd AT, Hyland JM, O'Donoghue DP, Sheahan K, Leahy DT, Mulcahy HE, O'Sullivan JN. Coss A, et al. Cancer Lett. 2009 Apr 18;276(2):228-38. doi: 10.1016/j.canlet.2008.11.018. Epub 2008 Dec 25. Cancer Lett. 2009. PMID: 19111388

4

High clusterin expression correlates with a poor outcome in stage II colorectal cancers.

Kevans D, Foley J, Tenniswood M, Sheahan K, Hyland J, O'Donoghue D, Mulcahy H, O'Sullivan J. Kevans D, et al. Cancer Epidemiol Biomarkers Prev. 2009 Feb;18(2):393-9. doi: 10.1158/1055-9965.EPI-08-0302. Epub 2009 Jan 20. Cancer Epidemiol Biomarkers Prev. 2009. PMID: 19155441

5

Localization of nuclear cathepsin L and its association with disease progression and poor outcome in colorectal cancer.

Sullivan S, Tosetto M, Kevans D, Coss A, Wang L, O'Donoghue D, Hyland J, Sheahan K, Mulcahy H, O'Sullivan J. Sullivan S, et al. Int J Cancer. 2009 Jul 1;125(1):54-61. doi: 10.1002/ijc.24275. Int J Cancer. 2009. PMID: 19291794 Free article.

6

Radiation and chemotherapy bystander effects induce early genomic instability events: telomere shortening and bridge formation coupled with mitochondrial dysfunction.

Gorman S, Tosetto M, Lyng F, Howe O, Sheahan K, O'Donoghue D, Hyland J, Mulcahy H, O'Sullivan J. Gorman S, et al. Mutat Res. 2009 Oct 2;669(1-2):131-8. doi: 10.1016/j.mrfmmm.2009.06.003. Epub 2009 Jun 18. Mutat Res. 2009. PMID: 19540247

7

Mitochondrial mutagenesis induced by tumor-specific radiation bystander effects.

Gorman S, Fox E, O'Donoghue D, Sheahan K, Hyland J, Mulcahy H, Loeb LA, O'Sullivan J. Gorman S, et al. J Mol Med (Berl). 2010 Jul;88(7):701-8. doi: 10.1007/s00109-010-0616-3. Epub 2010 Mar 28. J Mol Med (Berl). 2010. PMID: 20349220

8

Clinical and pathological factors associated with colorectal cancer at the upper extreme of life.

Doherty G, Walsh P, Sheridan J, Kevans D, Keegan D, Nolan B, White A, McDermott E, Sheahan K, O'Shea D, Hyland J, O'Donoghue D, O'Sullivan J, Mulcahy H. Doherty G, et al. J Am Geriatr Soc. 2010 Apr;58(4):794-5. doi: 10.1111/j.1532-5415.2010.02793.x. J Am Geriatr Soc. 2010. PMID: 20398168 No abstract available.

9

Clusterin and chemotherapy sensitivity under normoxic and graded hypoxic conditions in colorectal cancer.

Kevans D, Gorman S, Tosetto M, Sheahan K, O'Donoghue D, Mulcahy H, O'Sullivan J. Kevans D, et al. J Gastrointest Cancer. 2012 Jun;43(2):305-13. doi: 10.1007/s12029-011-9277-x. J Gastrointest Cancer. 2012. PMID: 21487682

10

Epithelial-mesenchymal transition (EMT) protein expression in a cohort of stage II colorectal cancer patients with characterized tumor budding and mismatch repair protein status.

Kevans D, Wang LM, Sheahan K, Hyland J, O'Donoghue D, Mulcahy H, O'Sullivan J. Kevans D, et al. Int J Surg Pathol. 2011 Dec;19(6):751-60. doi: 10.1177/1066896911414566. Epub 2011 Jul 26. Int J Surg Pathol. 2011. PMID: 21791486

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,810 results

Search Page